JB

Jeanne Bolger

Non Executive Director at Kingdom Therapeutics Ltd

Greater Dublin

Overview 

Jeanne Bolger is a highly experienced Life Sciences Consultant and Board member based in Greater Dublin, with a background in business strategy, executive management, and mergers & acquisitions. She currently holds key leadership roles as Chairperson of the Board at ExeVir and AviadoBio, showcasing her expertise in guiding start-ups and established companies within the pharmaceuticals and biotech sectors. Bolger's career highlights include serving as Vice President Venture Investing at Johnson & Johnson Innovation - JJDC, Inc., and holding multiple Non-Executive Director positions in prominent life sciences companies like Kingdom Therapeutics Ltd and S-Biomedic, demonstrating her strong leadership and strategic acumen in the industry.

Work Experience 

LH

Life Healthcare

  • Independent Non-Executive Director

    2022 - Current

    Leading provider of hospital and out-patient services in Southern Africa, specialist radiology diagnostic services, radio-isotope bio-marker development and radio pharmacy operations in EU

KT

Kingdom Therapeutics Ltd

  • Non Executive Director

    2022

    Kingdom Therapeutics (Kingdom) is an early-stage UK & Irish, biopharmaceutical company focused on applying a rigorous approach to the promising field of the endocannabinoid system for children with Autism Spectrum Disorder (ASD).

A

AstriVax

  • Non Executive Chair

    2022

E

ExeVir

  • Chairperson of the Board

    2022

    Biotech engaged in drug discovery and development of therapeutics in the infectious disease space including COVID-19, based on VHH-nanobody platform and targeting vulnerable immunocompromised populations as well as pandemic preparedness

S

S-Biomedic

  • Non Executive Board Member

    2022 - 2022

    Skin microbiome company, acquired by Beiersdorf in Dec 2022

S-Biomedic is a skin microbiome research pioneer Company.

Raised $6,085,345.00 from European Innovation Council.

sbiomedic.com

AviadoBio

  • Chairperson of the Board

    2020 - 2022

AS

Asceneuron SA

  • Board Member

    2015 - 2022

    Discovering and developing ground-breaking therapeutics for neurodegenerative therapeutics

Johnson & Johnson Innovation - JJDC, Inc.

  • Vice President Venture Investing

    2013 - 2022

    VP Investor with JJDC, Johnson & Johnson's Corporate Venture firm.. Based at the London Innovation Centre. Focus on investments in early to late stage pharmaceuticals / biotech companies in areas of strategic interest to Johnson & Johnson.

T

TRexBio

  • Director Board Of Directors

    2019 - 2022

S

S-Biomedic

  • Board Member

    2016 - 2021

S-Biomedic is a skin microbiome research pioneer Company.

Raised $6,085,345.00 from European Innovation Council.

sbiomedic.com

Education 

Articles About Jeanne

Relevant Websites